← Research status explorer
Peak / Growth axis
Ipamorelin
Current research status
Human Research
Human pharmacology/clinical research
Preclinical
Human Research
Overview
Ipamorelin is a selective ghrelin-receptor agonist (growth hormone secretagogue) studied in human pharmacology trials, including in combination with GHRH analogues, for its growth-hormone-releasing effects with comparatively little impact on cortisol or prolactin. It has not completed a conventional Phase 1–3 program leading to drug approval.
Sources
Last reviewed: September 2026
